Phase 1B/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients

Van Schaeybroeck, Sandra (PI)
Johnston, Patrick (CoI)
Kennedy, Richard (CoI)
Lawler, Mark (CoI)
Longley, Daniel (CoI)
Salto-Tellez, Manuel (CoI)
Wilson, Richard (CoI)

School of Medicine, Dentistry and Biomedical Sciences

Acronym	R6416CNR
Status	Finished
Effective start/end date	01/08/2013 → 30/11/2020